United States Lapatinib Market Report 2017

October 2017 | 103 pages | ID: U4971480C43PEN
QYResearch

Abstracts

In this report, the United States Lapatinib market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Lapatinib in these regions, from 2012 to 2022 (forecast).

United States Lapatinib market competition by top manufacturers/players, with Lapatinib sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Genentech Inc
• Novartis AG
• Pfizer
• Abnova Corporation
• InvivoGen
• Celltrion
• Biocon Limited
• Bio-Techne

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Human Source
• Animal Source

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Lapatinib for each application, including

• Hospital
• Medical Center

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Lapatinib Market Report 2017

1 LAPATINIB OVERVIEW

1.1 Product Overview and Scope of Lapatinib
1.2 Classification of Lapatinib by Product Category
  1.2.1 United States Lapatinib Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Lapatinib Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Human Source
  1.2.4 Animal Source
1.3 United States Lapatinib Market by Application/End Users
  1.3.1 United States Lapatinib Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Medical Center
1.4 United States Lapatinib Market by Region
  1.4.1 United States Lapatinib Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Lapatinib Status and Prospect (2012-2022)
  1.4.3 Southwest Lapatinib Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Lapatinib Status and Prospect (2012-2022)
  1.4.5 New England Lapatinib Status and Prospect (2012-2022)
  1.4.6 The South Lapatinib Status and Prospect (2012-2022)
  1.4.7 The Midwest Lapatinib Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Lapatinib (2012-2022)
  1.5.1 United States Lapatinib Sales and Growth Rate (2012-2022)
  1.5.2 United States Lapatinib Revenue and Growth Rate (2012-2022)

2 UNITED STATES LAPATINIB MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Lapatinib Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Lapatinib Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Lapatinib Average Price by Players/Suppliers (2012-2017)
2.4 United States Lapatinib Market Competitive Situation and Trends
  2.4.1 United States Lapatinib Market Concentration Rate
  2.4.2 United States Lapatinib Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Lapatinib Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES LAPATINIB SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Lapatinib Sales and Market Share by Region (2012-2017)
3.2 United States Lapatinib Revenue and Market Share by Region (2012-2017)
3.3 United States Lapatinib Price by Region (2012-2017)

4 UNITED STATES LAPATINIB SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Lapatinib Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Lapatinib Revenue and Market Share by Type (2012-2017)
4.3 United States Lapatinib Price by Type (2012-2017)
4.4 United States Lapatinib Sales Growth Rate by Type (2012-2017)

5 UNITED STATES LAPATINIB SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Lapatinib Sales and Market Share by Application (2012-2017)
5.2 United States Lapatinib Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES LAPATINIB PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Genentech Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Lapatinib Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Genentech Inc Lapatinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Novartis AG
  6.2.2 Lapatinib Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis AG Lapatinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.2 Lapatinib Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Lapatinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Abnova Corporation
  6.4.2 Lapatinib Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Abnova Corporation Lapatinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 InvivoGen
  6.5.2 Lapatinib Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 InvivoGen Lapatinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Celltrion
  6.6.2 Lapatinib Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Celltrion Lapatinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Biocon Limited
  6.7.2 Lapatinib Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Biocon Limited Lapatinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bio-Techne
  6.8.2 Lapatinib Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bio-Techne Lapatinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 LAPATINIB MANUFACTURING COST ANALYSIS

7.1 Lapatinib Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Lapatinib

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Lapatinib Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Lapatinib Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES LAPATINIB MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Lapatinib Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Lapatinib Sales Volume Forecast by Type (2017-2022)
11.3 United States Lapatinib Sales Volume Forecast by Application (2017-2022)
11.4 United States Lapatinib Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Lapatinib
Figure United States Lapatinib Market Size (K Pcs) by Type (2012-2022)
Figure United States Lapatinib Sales Volume Market Share by Type (Product Category) in 2016
Figure Human Source Product Picture
Figure Animal Source Product Picture
Figure United States Lapatinib Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Lapatinib by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure United States Lapatinib Market Size (Million USD) by Region (2012-2022)
Figure The West Lapatinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Lapatinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Lapatinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Lapatinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Lapatinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Lapatinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Lapatinib Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Lapatinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Lapatinib Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Lapatinib Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Lapatinib Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Lapatinib Sales Share by Players/Suppliers
Figure 2017 United States Lapatinib Sales Share by Players/Suppliers
Figure United States Lapatinib Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Lapatinib Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Lapatinib Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Lapatinib Revenue Share by Players/Suppliers
Figure 2017 United States Lapatinib Revenue Share by Players/Suppliers
Table United States Market Lapatinib Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Lapatinib Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Lapatinib Market Share of Top 3 Players/Suppliers
Figure United States Lapatinib Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Lapatinib Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Lapatinib Product Category
Table United States Lapatinib Sales (K Pcs) by Region (2012-2017)
Table United States Lapatinib Sales Share by Region (2012-2017)
Figure United States Lapatinib Sales Share by Region (2012-2017)
Figure United States Lapatinib Sales Market Share by Region in 2016
Table United States Lapatinib Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Lapatinib Revenue Share by Region (2012-2017)
Figure United States Lapatinib Revenue Market Share by Region (2012-2017)
Figure United States Lapatinib Revenue Market Share by Region in 2016
Table United States Lapatinib Price (USD/Pcs) by Region (2012-2017)
Table United States Lapatinib Sales (K Pcs) by Type (2012-2017)
Table United States Lapatinib Sales Share by Type (2012-2017)
Figure United States Lapatinib Sales Share by Type (2012-2017)
Figure United States Lapatinib Sales Market Share by Type in 2016
Table United States Lapatinib Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Lapatinib Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Lapatinib by Type (2012-2017)
Figure Revenue Market Share of Lapatinib by Type in 2016
Table United States Lapatinib Price (USD/Pcs) by Types (2012-2017)
Figure United States Lapatinib Sales Growth Rate by Type (2012-2017)
Table United States Lapatinib Sales (K Pcs) by Application (2012-2017)
Table United States Lapatinib Sales Market Share by Application (2012-2017)
Figure United States Lapatinib Sales Market Share by Application (2012-2017)
Figure United States Lapatinib Sales Market Share by Application in 2016
Table United States Lapatinib Sales Growth Rate by Application (2012-2017)
Figure United States Lapatinib Sales Growth Rate by Application (2012-2017)
Table Genentech Inc Basic Information List
Table Genentech Inc Lapatinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Genentech Inc Lapatinib Sales Growth Rate (2012-2017)
Figure Genentech Inc Lapatinib Sales Market Share in United States (2012-2017)
Figure Genentech Inc Lapatinib Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Lapatinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis AG Lapatinib Sales Growth Rate (2012-2017)
Figure Novartis AG Lapatinib Sales Market Share in United States (2012-2017)
Figure Novartis AG Lapatinib Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Lapatinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Lapatinib Sales Growth Rate (2012-2017)
Figure Pfizer Lapatinib Sales Market Share in United States (2012-2017)
Figure Pfizer Lapatinib Revenue Market Share in United States (2012-2017)
Table Abnova Corporation Basic Information List
Table Abnova Corporation Lapatinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abnova Corporation Lapatinib Sales Growth Rate (2012-2017)
Figure Abnova Corporation Lapatinib Sales Market Share in United States (2012-2017)
Figure Abnova Corporation Lapatinib Revenue Market Share in United States (2012-2017)
Table InvivoGen Basic Information List
Table InvivoGen Lapatinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure InvivoGen Lapatinib Sales Growth Rate (2012-2017)
Figure InvivoGen Lapatinib Sales Market Share in United States (2012-2017)
Figure InvivoGen Lapatinib Revenue Market Share in United States (2012-2017)
Table Celltrion Basic Information List
Table Celltrion Lapatinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Celltrion Lapatinib Sales Growth Rate (2012-2017)
Figure Celltrion Lapatinib Sales Market Share in United States (2012-2017)
Figure Celltrion Lapatinib Revenue Market Share in United States (2012-2017)
Table Biocon Limited Basic Information List
Table Biocon Limited Lapatinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biocon Limited Lapatinib Sales Growth Rate (2012-2017)
Figure Biocon Limited Lapatinib Sales Market Share in United States (2012-2017)
Figure Biocon Limited Lapatinib Revenue Market Share in United States (2012-2017)
Table Bio-Techne Basic Information List
Table Bio-Techne Lapatinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bio-Techne Lapatinib Sales Growth Rate (2012-2017)
Figure Bio-Techne Lapatinib Sales Market Share in United States (2012-2017)
Figure Bio-Techne Lapatinib Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Lapatinib
Figure Manufacturing Process Analysis of Lapatinib
Figure Lapatinib Industrial Chain Analysis
Table Raw Materials Sources of Lapatinib Major Players/Suppliers in 2016
Table Major Buyers of Lapatinib
Table Distributors/Traders List
Figure United States Lapatinib Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Lapatinib Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Lapatinib Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Lapatinib Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Lapatinib Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Lapatinib Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Lapatinib Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Lapatinib Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Lapatinib Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Lapatinib Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Lapatinib Sales Volume Share Forecast by Region (2017-2022)
Figure United States Lapatinib Sales Volume Share Forecast by Region (2017-2022)
Figure United States Lapatinib Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources